| For: | Zhu FS, Liu S, Chen XM, Huang ZG, Zhang DW. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol 2008; 14(41): 6395-6400 [PMID: 19009658 DOI: 10.3748/wjg.14.6395] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i41/6395.htm |
| Number | Citing Articles |
| 1 |
S. Spahis, F. Alvarez, J. Dubois, N. Ahmed, N. Peretti, E. Levy. Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: Effect of n-3 PUFA supplementation. Prostaglandins, Leukotrienes and Essential Fatty Acids 2015; 99 doi: 10.1016/j.plefa.2015.04.010
|
| 2 |
Natalia Mazzella, Laura M. Ricciardi, Arianna Mazzotti, Giulio Marchesini. The Role of Medications for the Management of Patients with NAFLD. Clinics in Liver Disease 2014; 18(1) doi: 10.1016/j.cld.2013.09.005
|
| 3 |
|
| 4 |
Shahinul Alam, Golam Mustafa, Mahabubul Alam, Nooruddin Ahmad. Insulin resistance in development and progression of nonalcoholic fatty liver disease. World Journal of Gastrointestinal Pathophysiology 2016; 7(2): 211-217 doi: 10.4291/wjgp.v7.i2.211
|
| 5 |
Marcin Kosmalski, Rafał Frankowski, Kacper Deska, Monika Różycka-Kosmalska, Tadeusz Pietras. Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds. Nutrients 2023; 15(13) doi: 10.3390/nu15132838
|
| 6 |
Fabien Wauquier, Laurent Léotoing, Claire Philippe, Mélanie Spilmont, Véronique Coxam, Yohann Wittrant. Pros and cons of fatty acids in bone biology. Progress in Lipid Research 2015; 58 doi: 10.1016/j.plipres.2015.03.001
|
| 7 |
Xi-Xi He, Xiao-Li Wu, Ren-Pin Chen, Chao Chen, Xiao-Gang Liu, Bin-Jiao Wu, Zhi-Ming Huang, Jonathan M Peterson. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. PLOS ONE 2016; 11(10) doi: 10.1371/journal.pone.0162368
|
| 8 |
Vasilios G. Athyros, Konstantinos Tziomalos, Georgios N. Daskalopoulos, Asterios Karagiannis, Dimitri P. Mikhailidis. Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?. Annals of Medicine 2011; 43(3) doi: 10.3109/07853890.2011.561363
|
| 9 |
Francesco Sofi, Ilaria Giangrandi, Francesca Cesari, Ilaria Corsani, Rosanna Abbate, Gian Franco Gensini, Alessandro Casini. Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study. International Journal of Food Sciences and Nutrition 2010; 61(8) doi: 10.3109/09637486.2010.487480
|
| 10 |
Virginia Fernández, Gladys Tapia, Luis A Videla. Recent advances in liver preconditioning: Thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron. World Journal of Hepatology 2012; 4(4): 119-128 doi: 10.4254/wjh.v4.i4.119
|
| 11 |
Shan Shi, Ziying Liu, Zhengyuan Xue, Xiaohui Chen, Yang Chu. A plasma metabonomics study on the therapeutic effects of the Si-miao-yong-an decoction in hyperlipidemic rats. Journal of Ethnopharmacology 2020; 256 doi: 10.1016/j.jep.2020.112780
|
| 12 |
Helen M. Parker, Jeffrey S. Cohn, Helen T. O’Connor, Manohar L. Garg, Ian D. Caterson, Jacob George, Nathan A. Johnson. Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial. Nutrients 2019; 11(2) doi: 10.3390/nu11020475
|
| 13 |
Zhan-yong Chen, Meng Liu, Li-peng Jing, Mian-li Xiao, Hong-li Dong, Geng-dong Chen, Yu-ming Chen. Erythrocyte membrane n-3 polyunsaturated fatty acids are inversely associated with the presence and progression of nonalcoholic fatty liver disease in Chinese adults: a prospective study. European Journal of Nutrition 2020; 59(3) doi: 10.1007/s00394-019-01953-2
|
| 14 |
Yasutaka Takeda, Masato Furuhashi, Ichiro Sakuma, Shinya Hiramitsu, Mizuho Okada, Shinichiro Ueda, Naoki Kumashiro, Masaru Sakurai. Comparison of the effects of pemafibrate and omega-3 fatty acid ethyl on fatty liver index in patients with dyslipidemia treated with statin: a sub-analysis from the PROUD48 study. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1549687
|
| 15 |
Zahra Yari, Azita Hekmatdoost. Dietary Interventions in Gastrointestinal Diseases. 2019; doi: 10.1016/B978-0-12-814468-8.00020-X
|
| 16 |
E. Scorletti, C.D. Byrne. Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease. Annual Review of Nutrition 2013; 33(1) doi: 10.1146/annurev-nutr-071812-161230
|
| 17 |
M. A. Shareef, T. R. Mohammed, Ahmed T. Ali, Hassan Muthana Alnori. Effect of Vitamins A, E, D3 Supplemented with Omega3 and Vitamins A, E, D3 (without Omega -3) on Biochemical Blood Parameters of Females Awassi Lamb. IOP Conference Series: Earth and Environmental Science 2023; 1259(1) doi: 10.1088/1755-1315/1259/1/012083
|
| 18 |
Helen M. Parker, Nathan A. Johnson, Catriona A. Burdon, Jeffrey S. Cohn, Helen T. O’Connor, Jacob George. Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis. Journal of Hepatology 2012; 56(4) doi: 10.1016/j.jhep.2011.08.018
|
| 19 |
Andrea J. Cussons, Gerald F. Watts, Trevor A. Mori, Bronwyn G. A. Stuckey. Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy. The Journal of Clinical Endocrinology & Metabolism 2009; 94(10) doi: 10.1210/jc.2009-0870
|
| 20 |
Minjie Lin, Shuiping Zhao, Li Shen, Danyan Xu. Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition. Drug Safety 2014; 37(4) doi: 10.1007/s40264-014-0147-x
|
| 21 |
Ying-Chun Wang, Wei-Zong Kong, Qing-Mei Jin, Juan Chen, Lei Dong. Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis. World Journal of Gastroenterology 2015; 21(35): 10104-10112 doi: 10.3748/wjg.v21.i35.10104
|
| 22 |
J. Bernadette Moore. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proceedings of the Nutrition Society 2010; 69(2) doi: 10.1017/S0029665110000030
|
| 23 |
Gladys Tapia, Rodrigo Valenzuela, Alejandra Espinosa, Pamela Romanque, Camila Dossi, Daniel Gonzalez-Mañán, Luis A. Videla, Amanda D'Espessailles. N-3long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation. Molecular Nutrition & Food Research 2014; 58(6) doi: 10.1002/mnfr.201300458
|
| 24 |
Dimitrios Papandreou, Eleni Andreou. Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World Journal of Hepatology 2015; 7(3): 575-582 doi: 10.4254/wjh.v7.i3.575
|
| 25 |
Donald B. Jump, Kelli A. Lytle, Christopher M. Depner, Sasmita Tripathy. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. Pharmacology & Therapeutics 2018; 181 doi: 10.1016/j.pharmthera.2017.07.007
|
| 26 |
Schohraya Spahis, Fernando Alvarez, Nejma Ahmed, Josée Dubois, Ramy Jalbout, Massimiliano Paganelli, Kelly Grzywacz, Edgard Delvin, Noel Peretti, Emile Levy. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids. The Journal of Nutritional Biochemistry 2018; 58 doi: 10.1016/j.jnutbio.2018.03.025
|
| 27 |
Seung Up Kim. Pharmacologic Treatment Using Non-Hypoglycemic Agents for Nonalcoholic Fatty Liver Disease. The Journal of Korean Diabetes 2018; 19(2) doi: 10.4093/jkd.2018.19.2.97
|
| 28 |
E. Scorletti, L. Bhatia, K.G. McCormick, G.F. Clough, K. Nash, P.C. Calder, C.D. Byrne. Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease. Contemporary Clinical Trials 2014; 37(2) doi: 10.1016/j.cct.2014.02.002
|
| 29 |
Yifan Wang, He Yi, Weixia Sun, Hekai Yu, Wenxuan Tao, Xiaojin Yu, Dianrong Jia, Yingzhao Liu, Stephen J. Pandol, Ling Li. Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials. Drugs 2024; 84(4) doi: 10.1007/s40265-024-02015-6
|
| 30 |
Limei Hua, Min Lei, Sujuan Xue, Xiaoling Li, Shaojian Li, Qi Xie. Effect of fish oil supplementation combined with high-intensity interval training in newly diagnosed non-obese type 2 diabetes: a randomized controlled trial. Journal of Clinical Biochemistry and Nutrition 2020; 66(2) doi: 10.3164/jcbn.19-64
|
| 31 |
Giovanni Musso, Roberto Gambino, Maurizio Cassader, Gianfranco Pagano. A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease. Hepatology 2010; 52(1) doi: 10.1002/hep.23623
|
| 32 |
Shanmugam M Jeyakumar, Ayyalasomayajula Vajreswari. Pharmaconutrition strategy to resolve SARS-CoV-2-induced inflammatory cytokine storm in non-alcoholic fatty liver disease: Omega-3 long-chain polyunsaturated fatty acids. World Journal of Clinical Cases 2021; 9(31): 9333-9349 doi: 10.12998/wjcc.v9.i31.9333
|
| 33 |
Ja Kyung Kim, Kwan Sik Lee, Dong Ki Lee, Su Yeon Lee, Hye Young Chang, Junjeong Choi, Jung Il Lee. Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice. Experimental & Molecular Medicine 2014; 46(12) doi: 10.1038/emm.2014.90
|
| 34 |
Silvia Marinho Ferolla, Luciana Costa Silva, Maria de Lourdes Abreu Ferrari, Aloísio Sales da Cunha, Flaviano dos Santos Martins, Cláudia Alves Couto, Teresa Cristina Abreu Ferrari. Dietary approach in the treatment of nonalcoholic fatty liver disease. World Journal of Hepatology 2015; 7(24): 2522-2534 doi: 10.4254/wjh.v7.i24.2522
|
| 35 |
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Amedeo Lonardo. The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans. Advances in Therapy 2016; 33(3) doi: 10.1007/s12325-016-0306-9
|
| 36 |
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2013; 19(4) doi: 10.3350/cmh.2013.19.4.325
|
| 37 |
E. B. Mitchel, J. E. Lavine. Review article: the management of paediatric nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2014; 40(10) doi: 10.1111/apt.12972
|
| 38 |
Eleonora Scorletti, Lokpal Bhatia, Keith G. McCormick, Geraldine F. Clough, Kathryn Nash, Leanne Hodson, Helen E. Moyses, Philip C. Calder, Christopher D. Byrne, Nick Sheron, Mark Wright, Nick Curzen, Dhrubo Rakhit, Charles Peebles, Angela Darekar, Alison Fletcher, Adrian Bateman, Elizabeth Williams, Richard Aspinall, Andrew Fowell, Tristan Richardson, J. S.W. Li Voon Chong, Maén Al-Mrayat. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study. Hepatology 2014; 60(4) doi: 10.1002/hep.27289
|
| 39 |
Raquel Cueto-Galán, Francisco Javier Barón, Pedro Valdivielso, Xavier Pintó, Emili Corbella, Enrique Gómez-Gracia, Julia Wärnberg. Cambios en el Índice de Hígado Graso con una intervención con dieta mediterránea: seguimiento de 6 años del ensayo PREDIMED-Málaga. Medicina Clínica 2017; 148(10) doi: 10.1016/j.medcli.2016.11.032
|
| 40 |
Tsung-Han Yang, Hsien-Tsung Yao, Meng-Tsan Chiang. Red algae ( Gelidium amansii ) hot-water extract ameliorates lipid metabolism in hamsters fed a high-fat diet. Journal of Food and Drug Analysis 2017; 25(4) doi: 10.1016/j.jfda.2016.12.008
|
| 41 |
Mohamed Abdallah, Landon Brown, John Provenza, Raseen Tariq, Smitha Gowda, Ashwani K. Singal. Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trials. Annals of Hepatology 2022; 27(6) doi: 10.1016/j.aohep.2022.100738
|
| 42 |
Kathleen E. Corey, Mary E. Rinella. Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences 2016; 61(5) doi: 10.1007/s10620-016-4083-8
|
| 43 |
M. Elias-Miró, M. B. Jiménez-Castro, M. Mendes-Braz, A. Casillas-Ramírez, C. Peralta. The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion Injury. PPAR Research 2012; 2012 doi: 10.1155/2012/802384
|
| 44 |
Antonella Mosca, Maria Rita Braghini, Andrea Pietrobattista, Anna Alisi, Andrea Vania. Efficacy of non-pharmacological treatments in pediatric MASLD: a review of the literature. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1667377
|
| 45 |
Dimitrios G Bouzianas, Stella D Bouziana, Apostolos I Hatzitolios. Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids. Nutrition Reviews 2013; 71(11) doi: 10.1111/nure.12073
|
| 46 |
Andriana C. Kaliora, Alexander Kokkinos, Anastacia Diolintzi, Maria Stoupaki, Aristea Gioxari, Panagiotis T. Kanellos, George V. Z. Dedoussis, Jiannis Vlachogiannakos, Constantinos Revenas, Spiros D. Ladas, Vaios T. Karathanos. The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: a randomized controlled intervention. Food & Function 2016; 7(11) doi: 10.1039/C6FO01040G
|
| 47 |
Oluyemi Komolafe, Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas JG Chase, Dominic Fritche, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021; 2021(7) doi: 10.1002/14651858.CD013157.pub2
|
| 48 |
Mariano Gallo Ruelas, Ivo Queiroz, Túlio Pimentel, Arthur Henrique Tavares, Maria L.R. Defante, Lucas M. Barbosa, Igor Eckert. Effects of seal oil supplementation on lipid profile biomarkers: A systematic review and meta-analysis of randomized controlled trials. Prostaglandins, Leukotrienes and Essential Fatty Acids 2025; 204 doi: 10.1016/j.plefa.2025.102666
|
| 49 |
Antonio Iannelli, Francesco Martini, Anne Sophie Schneck, Bijan Ghavami, Guillaume Baudin, Rodolphe Anty, Jean Gugenheim. Preoperative 4-Week Supplementation with Omega-3 Polyunsaturated Fatty Acids Reduces Liver Volume and Facilitates Bariatric Surgery in Morbidly Obese Patients. Obesity Surgery 2013; 23(11) doi: 10.1007/s11695-013-0942-y
|
| 50 |
Anna Simona Sasdelli, Francesca Alessandra Barbanti, Giulio Marchesini. Human Nutrition from the Gastroenterologist’s Perspective. 2016; doi: 10.1007/978-3-319-30361-1_8
|
| 51 |
Beth Conlon, Jeannette Beasley, Karin Aebersold, Sunil Jhangiani, Judith Wylie-Rosett. Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD). Nutrients 2013; 5(10) doi: 10.3390/nu5104093
|
| 52 |
Ma Ai Thanda Han, Qi Yu, Zaid Tafesh, Nikolaos Pyrsopoulos. Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally. Journal of Clinical and Translational Hepatology 2020; 0(000) doi: 10.14218/JCTH.2020.00082
|
| 53 |
Yinhua Ni, Fen Zhuge, Mayumi Nagashimada, Tsuguhito Ota. Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis. Nutrients 2016; 8(7) doi: 10.3390/nu8070391
|
| 54 |
Joaquín Pérez-Guisado, Andrés Muñoz-Serrano. The Effect of the Spanish Ketogenic Mediterranean Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study. Journal of Medicinal Food 2011; 14(7-8) doi: 10.1089/jmf.2011.0075
|
| 55 |
J. A. Tur, M. M. Bibiloni, A. Sureda, A. Pons. Dietary sources of omega 3 fatty acids: public health risks and benefits. British Journal of Nutrition 2012; 107(S2) doi: 10.1017/S0007114512001456
|
| 56 |
Jaechan Leem, Eun Hee Koh. Management of Non-alcoholic Fatty Liver Disease. The Journal of Korean Diabetes 2014; 15(2) doi: 10.4093/jkd.2014.15.2.93
|
| 57 |
SM Jeyakumar, A Vajreswari. Dietary Interventions in Liver Disease. 2019; doi: 10.1016/B978-0-12-814466-4.00030-6
|
| 58 |
Ahyoung Kim, Arunkumar Krishnan, James P. Hamilton, Tinsay A. Woreta. The Impact of Dietary Patterns and Nutrition in Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2021; 50(1) doi: 10.1016/j.gtc.2020.10.013
|
| 59 |
Nildem Kizilaslan, Nihal Zekiye Erdem, Muzaffer Katar, Fikret Gevrek, Marta Laranjo. The Effects of Probiotics and Omega‐3 Fatty Acids in Liver Steatosis Induced in Rats by High‐Fructose Corn Syrup. International Journal of Clinical Practice 2022; 2022(1) doi: 10.1155/2022/7172492
|
| 60 |
Jaime Morales-Romero, María Cristina Ortíz León, Héctor Hernández-Gutierrez, Roberto A. Bahena-Cerón, Aidé Miranda-Reza, José A. Marin-Carmona, Edit Rodríguez-Romero, Silvia I. Mora-Herrera, Jonathan Garcia-Roman, Julio I. Peréz-Carreón, Eduardo Rivadeneyra-Domínguez, Gabriel Riande-Juárez, Rebeca Garcia-Roman. Efficacy of nutrition therapy with food rich in methionine for treating nonalcoholic fatty liver. Archivos Latinoamericanos de Nutrición 2023; 73(2) doi: 10.37527/2023.73.2.004
|
| 61 |
Mariana Verdelho Machado, Helena Cortez-Pinto. Non-alcoholic fatty liver disease: What the clinician needs to know. World Journal of Gastroenterology 2014; 20(36): 12956-12980 doi: 10.3748/wjg.v20.i36.12956
|
| 62 |
Zi Zeng, Yuejuan Dong, Hua Wei, Sijin Sun, Zhuoma Sunu. Which oil truly benefits patients with metabolic dysfunction-associated steatotic liver disease? A systematic review and network meta-analysis. Nutrition Clinique et Métabolisme 2026; 40(3) doi: 10.1016/j.nupar.2026.103055
|
| 63 |
Bin Wang, Christopher Smyl, Chih-Yu Chen, Xiang-Yong Li, Wei Huang, Hong-Man Zhang, Victor J. Pai, Jing X. Kang. Suppression of Postprandial Blood Glucose Fluctuations by a Low-Carbohydrate, High-Protein, and High-Omega-3 Diet via Inhibition of Gluconeogenesis. International Journal of Molecular Sciences 2018; 19(7) doi: 10.3390/ijms19071823
|
| 64 |
Jinchunzi Yang, Marta Fernández-Galilea, Leyre Martínez-Fernández, Pedro González-Muniesa, Adriana Pérez-Chávez, J. Alfredo Martínez, Maria J. Moreno-Aliaga. Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation. Nutrients 2019; 11(4) doi: 10.3390/nu11040872
|
| 65 |
Schohraya Spahis, Edgard Delvin, Jean-Michel Borys, Emile Levy. Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis. Antioxidants & Redox Signaling 2017; 26(10) doi: 10.1089/ars.2016.6776
|
| 66 |
Rodrigo Valenzuela, Macarena Ortiz, María Catalina Hernández-Rodas, Francisca Echeverría, Luis Alberto Videla. Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease. Current Medicinal Chemistry 2020; 27(31) doi: 10.2174/0929867326666190410121716
|
| 67 |
Shaminie Athinarayanan, Yang‐Yi Fan, Xiaokun Wang, Evelyn Callaway, Defeng Cai, Naga Chalasani, Robert S. Chapkin, Wanqing Liu. Fatty Acid Desaturase 1 Influences Hepatic Lipid Homeostasis by Modulating the PPARα‐FGF21 Axis. Hepatology Communications 2021; 5(3) doi: 10.1002/hep4.1629
|
| 68 |
Luis A. Videla, Paulina Pettinelli. Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity. PPAR Research 2012; 2012 doi: 10.1155/2012/107434
|
| 69 |
Zahra Orang, Hassan Mozaffari-Khosravi, GholamReza Sivandzadeh, Ana Pantovic. The effect of omega-3 supplementation on glycemic indices and lipid profile in type 2 diabetic patients with non-alcoholic fatty liver disease: A double-blind, randomized, clinical trial. Mediterranean Journal of Nutrition and Metabolism 2019; 12(2) doi: 10.3233/MNM-180265
|
| 70 |
G. Musso, R. Gambino, M. Cassader. Non‐alcoholic fatty liver disease from pathogenesis to management: an update. Obesity Reviews 2010; 11(6) doi: 10.1111/j.1467-789X.2009.00657.x
|
| 71 |
Abbas Ali Sangouni, Zahra Orang, Hassan Mozaffari-Khosravi. Effect of omega-3 supplementation on fatty liver and visceral adiposity indices in diabetic patients with non-alcoholic fatty liver disease: A randomized controlled trial. Clinical Nutrition ESPEN 2021; 44 doi: 10.1016/j.clnesp.2021.06.015
|
| 72 |
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease. Clínica e Investigación en Arteriosclerosis (English Edition) 2017; 29(4) doi: 10.1016/j.artere.2017.07.001
|
| 73 |
Junhui Yang, Akriti Shrestha, Latha Ramalingam. Fishing for Solutions: How Pre‐Conceptional Fish Oil Supplementation in Obese Fathers Reduces Risk of Non‐Alcoholic Fatty Liver Disease in Offspring Mice. Molecular Nutrition & Food Research 2025; 69(5) doi: 10.1002/mnfr.202400452
|
| 74 |
Shubham Sharma, Anjali Sharma, Parul Gupta, Deepshi Arora, Geeta Deswal, Ajmer Grewal, Devkant Sharma. The Green Path to Liver Health: Herbal Solutions for Non-alcoholic Steatohepatitis. Cardiovascular & Hematological Disorders-Drug Targets 2025; 25(3) doi: 10.2174/011871529X360903250211101856
|
| 75 |
Carolina M. Perdomo, Gema Frühbeck, Javier Escalada. Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(3) doi: 10.3390/nu11030677
|
| 76 |
Bianca M. Arendt, Anastasia Teterina, Paulina Pettinelli, Elena M. Comelli, David W.L. Ma, Scott K. Fung, Ian D. McGilvray, Sandra E. Fischer, Johane P. Allard. Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease. Nutrition 2019; 62 doi: 10.1016/j.nut.2018.12.001
|
| 77 |
Su Jin Kim, Su Hwan Cho, Jae Moon Yun. Omega-3 polyunsaturated fatty acids and nonalcoholic fatty liver disease in adults: A meta-analysis of randomized controlled trials. Clinical Nutrition 2025; 50 doi: 10.1016/j.clnu.2025.05.013
|
| 78 |
. 2011; doi: 10.70675/4be08c33zb320z40e7z922fze4dfe7d75022
|
| 79 |
Caroline S. Stokes, Frank Lammert, Marcin Krawczyk. Short-term Dietary Interventions for the Management of Nonalcoholic Fatty Liver. Current Medicinal Chemistry 2019; 26(19) doi: 10.2174/0929867324666170508144409
|
| 80 |
Simon Lam, Stephen Doran, Hatice Hilal Yuksel, Ozlem Altay, Hasan Turkez, Jens Nielsen, Jan Boren, Mathias Uhlen, Adil Mardinoglu. Addressing the heterogeneity in liver diseases using biological networks. Briefings in Bioinformatics 2021; 22(2) doi: 10.1093/bib/bbaa002
|
| 81 |
Richele L. Corrado, Dawn M. Torres, Stephen A. Harrison. Review of Treatment Options for Nonalcoholic Fatty Liver Disease. Medical Clinics of North America 2014; 98(1) doi: 10.1016/j.mcna.2013.09.001
|
| 82 |
Eleonora Scorletti, Christopher D. Byrne. Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action. Molecular Aspects of Medicine 2018; 64 doi: 10.1016/j.mam.2018.03.001
|
| 83 |
Anne-Mari Mustonen, Vesa Kärjä, Michael Kilpiö, Raija Tammi, Markku Tammi, Kirsti Rouvinen-Watt, Toivo Halonen, Petteri Nieminen. Manifestations of Fasting-Induced Fatty Liver and Rapid Recovery from Steatosis in Voles Fed Lard or Flaxseed Oil Lipids. Nutrients 2013; 5(10) doi: 10.3390/nu5104211
|
| 84 |
Leanne Hodson, Fredrik Rosqvist, Siôn A Parry. The influence of dietary fatty acids on liver fat content and metabolism. Proceedings of the Nutrition Society 2020; 79(1) doi: 10.1017/S0029665119000569
|
| 85 |
Vasilios G Athyros, Konstantinos Tziomalos, Niki Katsiki, Michael Doumas, Asterios Karagiannis, Dimitri P Mikhailidis. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. World Journal of Gastroenterology 2015; 21(22): 6820-6834 doi: 10.3748/wjg.v21.i22.6820
|
| 86 |
Konstantinos Tziomalos. Lipid-lowering agents in the management of nonalcoholic fatty liver disease. World Journal of Hepatology 2014; 6(10): 738-744 doi: 10.4254/wjh.v6.i10.738
|
| 87 |
Valerio Nobili, Anna Alisi, Giovanni Musso, Eleonora Scorletti, Philip C. Calder, Christopher D. Byrne. Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD. Critical Reviews in Clinical Laboratory Sciences 2016; 53(2) doi: 10.3109/10408363.2015.1092106
|
| 88 |
Louise F. Clark, M. C. Thivierge, Claire A. Kidd, Susan C. McGeoch, Prakash Abraham, Donald W. M. Pearson, Graham W. Horgan, Grietje Holtrop, Frank Thies, Gerald E. Lobley. Fish oil supplemented for 9 months does not improve glycaemic control or insulin sensitivity in subjects with impaired glucose regulation: a parallel randomised controlled trial. British Journal of Nutrition 2016; 115(1) doi: 10.1017/S0007114515004274
|
| 89 |
Abbas Ali Sangouni, Zahra Orang, Hassan Mozaffari-Khosravi. Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial. BMC Nutrition 2021; 7(1) doi: 10.1186/s40795-021-00490-8
|
| 90 |
Mithun Sharma, Madhumita Premkumar, Anand V Kulkarni, Pramod Kumar, D Nageshwar Reddy, Nagaraja Padaki Rao. Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail. Journal of Clinical and Translational Hepatology 2020; 0(000) doi: 10.14218/JCTH.2020.00055
|
| 91 |
Fateme Doost Mohammadi, Reza Vazirinejad, Mohsen Rezaeian, Erfan Vazirinejad, Dariush Bastam, Hasan Ahmadinia, Roya Najafipour. Fast Food Consumption and the Risk of Non-Alcoholic Fatty Liver in Adults: A Community-Based Case-Control Study. Journal of Occupational Health and Epidemiology 2019; 8(4) doi: 10.29252/johe.8.4.176
|
| 92 |
Anna Jeznach-Steinhagen, Joanna Ostrowska, Aneta Czerwonogrodzka-Senczyna, Iwona Boniecka, Urszula Shahnazaryan, Alina Kuryłowicz. Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease. Medicina 2019; 55(5) doi: 10.3390/medicina55050166
|
| 93 |
Kathleen E. Corey, Naga Chalasani. Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology 2014; 12(7) doi: 10.1016/j.cgh.2013.08.014
|
| 94 |
Monize Aydar Nogueira, Claudia Pinto Oliveira, Venâncio Avancini Ferreira Alves, José Tadeu Stefano, Lívia Samara dos Reis Rodrigues, Raquel Susana Torrinhas, Bruno Cogliati, Hermes Barbeiro, Flair José Carrilho, Dan Linetzky Waitzberg. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition 2016; 35(3) doi: 10.1016/j.clnu.2015.05.001
|
| 95 |
Brian Lam, Zobair M. Younossi. Review: Treatment options for nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology 2010; 3(2) doi: 10.1177/1756283X09359964
|
| 96 |
Scott S. Malinowski, Jennifer S. Byrd, Allison M. Bell, Marion R. Wofford, Daniel M. Riche. Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease in Adults. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2013; 33(2) doi: 10.1002/phar.1190
|
| 97 |
Raquel Cueto-Galán, Francisco Javier Barón, Pedro Valdivielso, Xavier Pintó, Emili Corbella, Enrique Gómez-Gracia, Julia Wärnberg. Changes in fatty liver index after consuming a Mediterranean diet: 6-Year follow-up of the PREDIMED-Malaga trial. Medicina Clínica (English Edition) 2017; 148(10) doi: 10.1016/j.medcle.2017.04.030
|
| 98 |
José Illnait, Iván Rodríguez, Sarahí Mendoza, Yolanda Fernández, Rosa Mas, Mirtha Miranda, Jesús Piñera, Julio César Fernández, Meilis Mesa, Lilia Fernández, Daisy Carbajal, Rafael Gámez. Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease. The Korean Journal of Internal Medicine 2013; 28(4) doi: 10.3904/kjim.2013.28.4.439
|
| 99 |
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento (II). Tratamiento de la enfermedad del hígado graso no alcohólico. Clínica e Investigación en Arteriosclerosis 2017; 29(4) doi: 10.1016/j.arteri.2016.06.002
|
| 100 |
Rodrigo Valenzuela, Luis A. Videla. The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. Food & Function 2011; 2(11) doi: 10.1039/c1fo10133a
|
| 101 |
Jessica Monteiro, Michael Leslie, Mohammed H. Moghadasian, Bianca M. Arendt, Johane P. Allard, David W. L. Ma. The role of n − 6 and n − 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease. Food & Function 2014; 5(3) doi: 10.1039/c3fo60551e
|
| 102 |
Guo Jia, Zou Qiong, Wang Yonghua. Health effects of omega-3 polyunsaturated fatty acids in common diseases. International Food Research Journal 2021; 28(6) doi: 10.47836/ifrj.28.6.01
|
| 103 |
Eri Nanizawa, Yuki Katoh, Yuki Tamaki, Shun Otsuka, Naoyuki Hatayama, Tetsuya Ishikawa, Shuichi Hirai, Munekazu Naito. Preventive effect of eicosapentaenoic acid on the exacerbation of concanavalin A–induced liver injury aggravated by a short-term high-fat diet. The Journal of Nutritional Biochemistry 2025; 146 doi: 10.1016/j.jnutbio.2025.110049
|
| 104 |
Swastik Agrawal, Ajay K Duseja. Non-alcoholic Fatty Liver Disease: East Versus West. Journal of Clinical and Experimental Hepatology 2012; 2(2) doi: 10.1016/S0973-6883(12)60101-7
|
| 105 |
Francisca Herrera Vielma, Rodrigo Valenzuela, Luis A. Videla, Jessica Zúñiga-Hernández. N-3 Polyunsaturated Fatty Acids and Their Lipid Mediators as A Potential Immune–Nutritional Intervention: A Molecular and Clinical View in Hepatic Disease and Other Non-Communicable Illnesses. Nutrients 2021; 13(10) doi: 10.3390/nu13103384
|
| 106 |
Kathy Musa-Veloso, Carolina Venditti, Han Youl Lee, Maryse Darch, Seth Floyd, Spencer West, Ryan Simon. Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease. Nutrition Reviews 2018; 76(8) doi: 10.1093/nutrit/nuy022
|
| 107 |
Gabriela S. de Castro, Philip C. Calder. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clinical Nutrition 2018; 37(1) doi: 10.1016/j.clnu.2017.01.006
|
| 108 |
Jessica Monteiro, Fatemeh Askarian, Manabu T. Nakamura, Mohammed H. Moghadasian, David W.L. Ma. Oils rich in α-linolenic acid independently protect against characteristics of fatty liver disease in the Δ6-desaturase null mouse. Canadian Journal of Physiology and Pharmacology 2013; 91(6) doi: 10.1139/cjpp-2012-0308
|
| 109 |
Chunjiong Wang, Wenli Liu, Liu Yao, Xuejiao Zhang, Xu Zhang, Chenji Ye, Hongfeng Jiang, Jinlong He, Yi Zhu, Ding Ai. Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease. British Journal of Pharmacology 2017; 174(14) doi: 10.1111/bph.13844
|
| 110 |
Arpita Das, Yu Lung Malcolm Tang, Nora A. Althumiri, Vanessa Garcia-Larsen, Jörn M. Schattenberg, Saleh A. Alqahtani. Fatty acid composition but not quantity is an important indicator of non-alcoholic fatty liver disease: a systematic review. European Journal of Clinical Nutrition 2023; 77(12) doi: 10.1038/s41430-023-01335-2
|
| 111 |
Amirhossein Sahebkar, Gerard T. Chew, Gerald F. Watts. Recent advances in pharmacotherapy for hypertriglyceridemia. Progress in Lipid Research 2014; 56 doi: 10.1016/j.plipres.2014.07.002
|
| 112 |
David Højland Ipsen, Pernille Tveden‐Nyborg, Jens Lykkesfeldt. Normal weight dyslipidemia: Is it all about the liver?. Obesity 2016; 24(3) doi: 10.1002/oby.21443
|
| 113 |
Aline B. Arouca, Alba M. Santaliestra-Pasías, Luis A. Moreno, Ascensión Marcos, Kurt Widhalm, Dénes Molnár, Yannis Manios, Frederic Gottrand, Anthony Kafatos, Mathilde Kersting, Michael Sjöström, Ángel Gutiérrez Sáinz, Marika Ferrari, Inge Huybrechts, Marcela González-Gross, Maria Forsner, Stefaan De Henauw, Nathalie Michels. Diet as a moderator in the association of sedentary behaviors with inflammatory biomarkers among adolescents in the HELENA study. European Journal of Nutrition 2019; 58(5) doi: 10.1007/s00394-018-1764-4
|
| 114 |
Hideki Fujii, Norifumi Kawada. Inflammation and fibrogenesis in steatohepatitis. Journal of Gastroenterology 2012; 47(3) doi: 10.1007/s00535-012-0527-x
|
| 115 |
Stefania Basili, Valeria Raparelli, Laura Napoleone, Maria Del Ben, Manuela Merli, Oliviero Riggio, Cristina Nocella, Roberto Carnevale, Pasquale Pignatelli, Francesco Violi, Francesco Angelico, Daria Amoroso, Simona Bartimoccia, Vito Lelio Burgio, Cinzia Calabrese, Alessia Carboni, Olivia De Felice, Serena Di Santo, Valerio Giannelli, Cristina Lucidi, Carmen Nigro, Francesca Serena Pignataro, Marco Proietti, Roberta Russo, Giovanni Talerico. Polyunsaturated fatty acids balance affects platelet NOX2 activity in patients with liver cirrhosis. Digestive and Liver Disease 2014; 46(7) doi: 10.1016/j.dld.2014.02.021
|
| 116 |
William N. Hannah, Stephen A. Harrison. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2016; 20(2) doi: 10.1016/j.cld.2015.10.008
|
| 117 |
Min‐Hsiung Pan, Ching‐Shu Lai, Mei‐Ling Tsai, Chi‐Tang Ho. Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds. Molecular Nutrition & Food Research 2014; 58(1) doi: 10.1002/mnfr.201300522
|
| 118 |
Jung Mi Han, An Na Jo, Seung Min Lee, Hyun Suk Bae, Dae Won Jun, Yong Kyun Cho, Ki Tae Suk, Jai Hoon Yoon, Sang Bong Ahn, Yong Jin Cho, Seong Woo Kim, Eun Chul Jang. Associations between intakes of individual nutrients or whole food groups and non‐alcoholic fatty liver disease among Korean adults. Journal of Gastroenterology and Hepatology 2014; 29(6) doi: 10.1111/jgh.12520
|
| 119 |
Paola Dongiovanni, Claudia Lanti, Patrizia Riso, Luca Valenti. Nutritional therapy for nonalcoholic fatty liver disease. The Journal of Nutritional Biochemistry 2016; 29 doi: 10.1016/j.jnutbio.2015.08.024
|
| 120 |
Aline Arouca, Luis A. Moreno, Esther M. Gonzalez-Gil, Ascensión Marcos, Kurt Widhalm, Dénes Molnár, Yannis Manios, Frederic Gottrand, Anthony Kafatos, Mathilde Kersting, Michael Sjöström, Francisco J. Amaro-Gahete, Marika Ferrari, Inge Huybrechts, Marcela Gonzalez-Gross, Stefaan De Henauw, Nathalie Michels. Diet as moderator in the association of adiposity with inflammatory biomarkers among adolescents in the HELENA study. European Journal of Nutrition 2019; 58(5) doi: 10.1007/s00394-018-1749-3
|
| 121 |
Kátia Cansanção, Marta Citelli, Nathalie Carvalho Leite, María-Carmen López de las Hazas, Alberto Dávalos, Maria das Graças Tavares do Carmo, Wilza Arantes Ferreira Peres. Impact of Long-Term Supplementation with Fish Oil in Individuals with Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Placebo Controlled Clinical Trial. Nutrients 2020; 12(11) doi: 10.3390/nu12113372
|
| 122 |
Sanjeev R. Mehta. Review: Advances in the treatment of nonalcoholic fatty liver disease. Therapeutic Advances in Endocrinology and Metabolism 2010; 1(3) doi: 10.1177/2042018810379587
|
| 123 |
Cheng-Han Lee, Yun Fu, Shih-Jyun Yang, Ching-Chi Chi. Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis. Nutrients 2020; 12(9) doi: 10.3390/nu12092769
|
| 124 |
Thórdís Kristmundsdóttir, Skúli Skúlason. Lipids and Essential Oils as Antimicrobial Agents. 2011; doi: 10.1002/9780470976623.ch7
|
| 125 |
João V. S. Guerra, Marieli M. G. Dias, Anna J. V. C. Brilhante, Maiara F. Terra, Marta García-Arévalo, Ana Carolina M. Figueira. Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases. Nutrients 2021; 13(8) doi: 10.3390/nu13082830
|
| 126 |
Jian-Hui Yan, Bing-Jie Guan, Hai-Yan Gao, Xian-E Peng. Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease. Medicine 2018; 97(37) doi: 10.1097/MD.0000000000012271
|
| 127 |
Newaz Hossain, Pushpjeet Kanwar, Smruti R. Mohanty. A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/7109270
|
| 128 |
Stergios A. Polyzos, Jannis Kountouras, Christos Zavos, Eleni Tsiaousi. The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease. Diabetes, Obesity and Metabolism 2010; 12(5) doi: 10.1111/j.1463-1326.2009.01176.x
|
| 129 |
Xiao-fei Guo, Wen-Jun Ma. Advances in Dietary Lipids and Human Health. 2022; doi: 10.1016/B978-0-12-823914-8.00009-4
|
| 130 |
Anthony Fardet, Jean-François Martin, Jean-Michel Chardigny. Thermal and refining processes, not fermentation, tend to reduce lipotropic capacity of plant-based foods. Food & Function 2011; 2(8) doi: 10.1039/c1fo10041f
|
| 131 |
Giuseppe Della Pepa, Claudia Vetrani, Gianluca Lombardi, Lutgarda Bozzetto, Giovanni Annuzzi, Angela Rivellese. Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals. Nutrients 2017; 9(10) doi: 10.3390/nu9101065
|
| 132 |
Fatma Mert-Biberoğlu, Nihal Zekiye Erdem, Yaşar Özdenkaya, Ekrem Musa Özdemir, Burcu Saka. Effects of Whey Protein, Omega-3 Fatty Acid and Roux-En-Y Gastric Bypass on Body Weight, Biochemical Parameters and Organ Functions in an Obese Rat Model: Experimental Research. Obesity Surgery 2023; 33(5) doi: 10.1007/s11695-023-06560-z
|
| 133 |
Samer Gawrieh, Naga Chalasani. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; doi: 10.1007/978-3-319-20538-0_16
|
| 134 |
Suzanne E. Mahady, Jacob George. Management of Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2012; 16(3) doi: 10.1016/j.cld.2012.05.003
|
| 135 |
Nirvair S. Kelley. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans. Metabolic Syndrome and Related Disorders 2016; 14(9) doi: 10.1089/met.2016.0051
|
| 136 |
Wenxia Lu, Sainan Li, Jingjing Li, Jianrong Wang, Rong Zhang, Yuqing Zhou, Qin Yin, Yuanyuan Zheng, Fan Wang, Yujing Xia, Kan Chen, Tong Liu, Jie Lu, Yingqun Zhou, Chuanyong Guo. Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/1459790
|
| 137 |
Mauro Maurantonio, Stefano Ballestri, Maria Rosaria Odoardi, Amedeo Lonardo, Paola Loria. Treatment of Atherogenic Liver Based on the Pathogenesis of Nonalcoholic Fatty Liver Disease: A Novel Approach to Reduce Cardiovascular Risk?. Archives of Medical Research 2011; 42(5) doi: 10.1016/j.arcmed.2011.08.004
|
| 138 |
Beibei Zhou, Chao Lin, Saili Xie, Xingxing Zhou, Fan Zhang, Xuemei Ye, Feiyan Lin, Lufeng Hu, Aifang Huang. Determination of four omega-3 polyunsaturated fatty acids by UPLC-MS/MS in plasma of hyperlipidemic and normolipidemic subjects. Journal of Chromatography B 2019; doi: 10.1016/j.jchromb.2019.121762
|
| 139 |
Tannaz Eslamparast, Puneeta Tandon, Maitreyi Raman. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 2017; 9(8) doi: 10.3390/nu9080800
|
| 140 |
Fereidoon Shahidi, HYing Joy Zhong, Zhuliang Tan. Bailey's Industrial Oil and Fat Products. 2020; doi: 10.1002/047167849X.bio070.pub2
|
| 141 |
N Nishikata, N Shikata, Y Kimura, Y Noguchi. Dietary lipid-dependent regulation of de novo lipogenesis and lipid partitioning by ketogenic essential amino acids in mice. Nutrition & Diabetes 2011; 1(3) doi: 10.1038/nutd.2011.1
|
| 142 |
Tarique Aziz, Mukesh K Niraj, Shishir Kumar, Rajendra Kumar, Hina Parveen. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Cureus 2024; doi: 10.7759/cureus.68002
|
| 143 |
Yasar Colak, Ilyas Tuncer, Ebubekir Senates, Oguzhan Ozturk, Levent Doganay, Yusuf Yilmaz. Nonalcoholic Fatty Liver Disease: A Nutritional Approach. Metabolic Syndrome and Related Disorders 2012; 10(3) doi: 10.1089/met.2011.0145
|
| 144 |
Xiao-fei Guo, Bo Yang, Jun Tang, Duo Li. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials. Clinical Nutrition 2018; 37(1) doi: 10.1016/j.clnu.2017.01.003
|
| 145 |
William Nseir, Julnar Mograbi, Murad Ghali. Lipid-Lowering Agents in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Human Studies. Digestive Diseases and Sciences 2012; 57(7) doi: 10.1007/s10620-012-2118-3
|
| 146 |
Kazuo Nakamoto, Tokio Obata, Akira Hirasawa, Ke Ih Kim, Soo Ryang Kim, Shogo Tokuyama. A Future Perspective on the Involvement of <i>n</i>-3 Polyunsaturated Fatty Acid in the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. YAKUGAKU ZASSHI 2016; 136(4) doi: 10.1248/yakushi.15-00264-4
|
| 147 |
Woo-Soon Choi. Effects of Omega-3 on Lipid and Liver Function Tests. The Korean Journal of Clinical Laboratory Science 2018; 50(2) doi: 10.15324/kjcls.2018.50.2.183
|
| 148 |
G. Musso, M. Cassader, F. Rosina, R. Gambino. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 2012; 55(4) doi: 10.1007/s00125-011-2446-4
|
| 149 |
M. -C. Lacasse, A. Tang, J. Dubois, F. Alvarez, S. Spahis, M. Chagnon, S. Deschênes, E. Levy. Monitoring the efficacy of omega-3 supplementation on liver steatosis and carotid intima-media thickness: a pilot study. Obesity Science & Practice 2017; 3(2) doi: 10.1002/osp4.91
|
| 150 |
Misa Ando, Hyeon-Cheol Lee-Okada, Takehiko Yokomizo. Molecular Mechanisms by Which Polyunsaturated Fatty Acids Suppress the Pathogenesis and Progression of NAFLD. YAKUGAKU ZASSHI 2025; 145(3) doi: 10.1248/yakushi.24-00177-2
|
| 151 |
Srinivasan Dasarathy, Jaividhya Dasarathy, Amer Khiyami, Lisa Yerian, Carol Hawkins, Ruth Sargent, Arthur J. McCullough. Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis. Journal of Clinical Gastroenterology 2015; 49(2) doi: 10.1097/MCG.0000000000000099
|
| 152 |
Marialena Mouzaki, Johane P. Allard. The Role of Nutrients in the Development, Progression, and Treatment of Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2012; 46(6) doi: 10.1097/MCG.0b013e31824cf51e
|